Sulaimon S, Kitchell B, Ehrhart E
Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois, 2001 South Lincoln Avenue, Urbana, IL 61801, USA.
J Comp Pathol. 2002 Aug-Oct;127(2-3):162-8. doi: 10.1053/jcpa.2002.0576.
Twenty-five formalin-fixed, paraffin wax-embedded canine melanomas were examined immunohistochemically by an immunoperoxidase method to assess their reactivity with three human melanoma-specific monoclonal antibodies (HMB-45, MEL-1, NK1/C3). HMB-45 and MEL-1 reacted with 22/25 (88%) and 18/25 (72%) of canine melanomas, respectively, but only after microwave antigen retrieval and pretreatment with potassium permanganate and oxalic acid (KMnO(4)/OA). Positive reactivity to HMB-45 and MEL-1 was as follows: oral melanomas, 13/16 and 9/16, respectively; cutaneous melanomas, 8/8 and 8/8; melanoma of the digit, 1/1 and 1/1; all pigmented melanomas, 16/18 and 14/18; all amelanotic tumours, 6/7 and 4/7. HMB-45 immunolabelling was characterized by a diffuse granular cytoplasmic pattern within the tumour cells, and MEL-1 labelling by a cytoplasmic pattern with sporadic nuclear localization. In most tumours the labelling was homogeneous, but some showed a multifocal distribution. Generally, a higher percentage of canine melanomas was labelled by HMB-45 than by MEL-1. NK1/C3 failed to label any of seven melanomas tested, regardless of KMnO(4)/OA-pretreatment. Of 16 non-melanocytic tumours (specificity controls), 15 showed no significant reactivity with HMB-45, the exception being one of three plasmacytomas. Immunolabelling by MEL-1 on non-melanocytic tumours was not pursued, due to the poor sensitivity of this antibody as compared with that of HMB-45.
采用免疫过氧化物酶法对25例经福尔马林固定、石蜡包埋的犬黑色素瘤进行免疫组织化学检查,以评估它们与三种人黑色素瘤特异性单克隆抗体(HMB-45、MEL-1、NK1/C3)的反应性。HMB-45和MEL-1分别与22/25(88%)和18/25(72%)的犬黑色素瘤发生反应,但仅在经过微波抗原修复以及用高锰酸钾和草酸(KMnO₄/OA)预处理之后。对HMB-45和MEL-1的阳性反应如下:口腔黑色素瘤分别为13/16和9/16;皮肤黑色素瘤为8/8和8/8;指部黑色素瘤为1/1和1/1;所有色素性黑色素瘤为16/18和14/18;所有无色素性肿瘤为6/7和4/7。HMB-45免疫标记的特征是肿瘤细胞内弥漫性颗粒状胞质模式,而MEL-1标记为伴有散在核定位的胞质模式。在大多数肿瘤中,标记是均匀的,但有些显示多灶性分布。一般来说,被HMB-45标记的犬黑色素瘤百分比高于MEL-1。无论是否经过KMnO₄/OA预处理,NK1/C3均未能标记所检测的7例黑色素瘤中的任何一例。在16例非黑色素细胞肿瘤(特异性对照)中,15例与HMB-45无明显反应,唯一例外是3例浆细胞瘤中的1例。由于与HMB-45相比该抗体敏感性较差,因此未对非黑色素细胞肿瘤进行MEL-1免疫标记。